Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endoscopic Studies II: Thoracocentesis01:26

Endoscopic Studies II: Thoracocentesis

1.7K
Thoracentesis(Thoracocentesis), commonly known as pleural tap, is a medical procedure where a 22 gauge needle is inserted into the pleural space, the area between the lung and chest wall. This procedure is commonly performed to diagnose or treat various respiratory disorders.
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...
1.7K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

554
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
554
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.3K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.3K
Flail Chest-II01:26

Flail Chest-II

755
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
755
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.0K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.0K
Pneumothorax-I01:26

Pneumothorax-I

1.8K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Reply regarding the European Respiratory Society and European Society of Thoracic Surgeons clinical practice guideline on fitness for curative intent treatment of lung cancer.

The European respiratory journal·2026
Same author

HER2 expression and <i>HER2</i> gene amplification in thymic epithelial tumors: a narrative review.

Mediastinum (Hong Kong, China)·2026
Same author

Bcl-xL blockade targets neutrophils and synergizes with chemotherapy in lung squamous cell carcinoma.

EMBO molecular medicine·2026
Same author

Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.

The Lancet. Respiratory medicine·2026
Same author

Differentiating benign and malignant solitary pulmonary nodules through exhaled breath analysis.

ERJ open research·2026

Related Experiment Video

Updated: Mar 2, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K

Intensive care in thoracic oncology.

Anne-Pascale Meert1, Bogdan Grigoriu2, Marc Licker3

  • 1Service des Soins Intensifs et Urgences Oncologiques et Oncologie Thoracique, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium ap.meert@bordet.be.

The European Respiratory Journal
|May 13, 2017
PubMed
Summary

Lung cancer patients admitted to intensive care often face complications from treatment or acute organ failure. Close medical team collaboration is vital for optimal patient care and outcomes.

More Related Videos

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

6.7K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.2K

Related Experiment Videos

Last Updated: Mar 2, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

11.1K
Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit
05:56

Monitoring Lung Function with Electrical Impedance Tomography in the Intensive Care Unit

Published on: September 6, 2024

6.7K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.2K

Area of Science:

  • Medicine
  • Oncology
  • Critical Care

Background:

  • Thoracic surgery for lung cancer carries high morbidity despite advancements.
  • Postoperative complications and acute organ failure significantly impact patient outcomes.
  • Effective fast-tracking and management are crucial for reducing mortality.

Purpose of the Study:

  • To analyze factors influencing intensive care unit (ICU) admission for lung cancer patients.
  • To identify predictors of mortality in severe post-thoracic surgery cases.
  • To emphasize the need for multidisciplinary collaboration in lung cancer patient care.

Main Methods:

  • Review of patient data for lung cancer admissions to intensive care.
  • Analysis of factors related to postprocedural care, complications, and organ failure.
  • Identification of mortality predictors including severity scores and organ dysfunction.

Main Results:

  • ICU mortality for severe complications ranges from 13% to 47%, with hospital mortality from 24% to 65%.
  • Key predictors of in-hospital mortality include severity scores, organ failure, and need for mechanical ventilation.
  • Cancer-related parameters remain prognostic for long-term survival post-discharge.

Conclusions:

  • Multidisciplinary partnerships among thoracic surgeons, anesthesiologists, pneumologists, intensivists, and oncologists are essential.
  • Evidence-based care, clinical pathways, and collaborative decision-making improve patient management.
  • Shared decision-making involving the medical team, patient, and relatives is crucial for ICU admission decisions.